Revvity Inc (BSP:R1VT34)
R$ 23.77 0 (0%) Market Cap: 81.00 Bil Enterprise Value: 93.46 Bil PE Ratio: 56.19 PB Ratio: 1.79 GF Score: 65/100

PerkinElmer Inc at Robert W Baird Global Healthcare Conference Transcript

Sep 10, 2020 / 12:30PM GMT
Release Date Price: R$23.84
Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

All right. We'll go ahead and get started. Thanks, everyone, for joining us today. I'm Catherine Schulte. I cover Life Sciences and Diagnostics here at Baird. We're very excited to have PerkinElmer here presenting with us today. Representing the company, we have the CFO, Jamie Mock; and the Vice President of IR, Bryan Kipp. So thanks so much to both of you for being here.

James M. Mock
PerkinElmer, Inc. - Senior VP & CFO

Thanks, Catherine.

Questions & Answers

Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

As far as the agenda today, we're going to dive right into Q&A. So if anyone in the audience has a question, please submit them through the web portal, and we will work them into our conversation. So with that, maybe just first, Jamie, for those who might not be as familiar with your business. Can you just give

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot